Vinge advises Abliva on the public offer from Pharming

Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of Abliva AB (publ). The total value of the offer is approximately SEK 725 million.

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.

Vinge is advising Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135 million before deduction of transaction costs.

Vinge advises Symrise on its public offer for Probi

Symrise AG has announced a public cash offer to the shareholders of Probi AB (publ) (“Probi”). The offer values Probi at approximately SEK 3,988 million. The shares in Probi are traded on Nasdaq Stockholm, Mid Cap.

Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)  

24SevenOffice is a listed company (First North Stockholm) that provides modular software for accounting, ERP and business services that automate processes using AI.

Vinge advises EQT X on its public offer for OEM International

EQT X, through its indirectly owned subsidiary Oak BidCo S.à r.l., has secured an ownership of 72.5% of the votes in OEM International Aktiebolag (publ) and has announced a public cash offer to all shareholders. The shares of OEM International are admitted to trading on Nasdaq Stockholm, Mid Cap. The total value of the offer is approximately SEK 15.2 billion.

Vinge has advised Sveafastigheter in connection with its listing on Nasdaq First North Premier Growth Market

Vinge has advised Sveafastigheter AB (publ) (”Sveafastigheter”) in connection with its listing on Nasdaq First North Premier Growth Market. The prospectus was published on 7 October 2024 and the first day of trading is 18 October 2024.

Vinge has advised Sveafastigheter in connection with its listing on Nasdaq First North Premier Growth Market

Vinge has advised Sveafastigheter AB (publ) (”Sveafastigheter”) in connection with its listing on Nasdaq First North Premier Growth Market. The prospectus was published on 7 October 2024 and the first day of trading is 18 October 2024.

Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)

Vinge has advised EQT IX (”EQT”) in connection with the sale of shares in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 17 September 2024.

Vinge advises Cinclus Pharma in connection with listing on Nasdaq Stockholm

Vinge advises Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) in connection with an offering of new ordinary shares and listing on Nasdaq Stockholm. The first day of trading is 20 June 2024.

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.

Vinge has advised Triton in connection with sale of shares in Ambea AB (publ)

In total, 7.6 million shares were placed at a price of SEK 64 per share, corresponding to a total value of approximately SEK 489 million.

Vinge advises Humana in its acquisition of Team Olivia Norge AS

Humana Group ("Humana") strengthens its offering of high-quality care services in Norway as Human Care Holding AS ("Humana Norway") has entered into an agreement to acquire Team Olivia Norge AS for a purchase price of million SEK 341 on a cash- and debt-free basis.

Vinge advises EQT Infrastructure VI on its public offer for OX2

EQT Infrastructure VI, through its indirectly owned subsidiary Otello BidCo AB, announces a recommended public offer to the shareholders of OX2 AB (publ) (“OX2”). The shares are admitted to trading on Nasdaq Stockholm, Large Cap.